Adrenalinum

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: Adrenalinum
Generic name: ADRENALINUM
Manufacturer: OHM PHARMA INC.
Product type: HUMAN OTC DRUG
SPL set ID: a2a444fa-4337-42e3-bb31-2289c42f057e
SPL ID: d450922f-3861-3f22-e053-2995a90a9c7d
Version: 3
Effective date: 2021-12-29
Source export date: 2026-10-12
Source partition: 1
Source file: https://download.open.fda.gov/drug/label/drug-label-0001-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-10-12/7928c8e8c6256620071a8b7e5b93eb8dfa543649c08d17a01ea02251012ba58c/drug-label-0001-of-0014.json.zip
Source manifest SHA-256: 7e6b178df8f32cac9a78e0f5d09c588344509b04fe41effb1dde9102e2a45be6
Import run: 20261013T011858Z
Imported at: 2026-10-13 01:25:27

Harmonized routes table
Harmonized routes
ORAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 9 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
brand name		Adrenalinum	openfda.brand_name
generic name		ADRENALINUM	openfda.generic_name
manufacturer name		OHM PHARMA INC.	openfda.manufacturer_name
ndc	package	66096-778-01	openfda.package_ndc
ndc	product	66096-778	openfda.product_ndc
ndc11	package	66096077801	derived:openfda.package_ndc
spl id		d450922f-3861-3f22-e053-2995a90a9c7d	id
spl set id		a2a444fa-4337-42e3-bb31-2289c42f057e	set_id
unii		YKH834O4BH	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

WARNINGS: Keep out of reach of children. If pregnant or breast-feeding, ask a health care professional before use. Stop use and ask a health care professional if symptoms persist for more than 3 days or worsen. Keep out of reach of children.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.